{
  "report_rows": [
    {
      "kpi": "Adj. EPS (2Q26)",
      "prediction": "BEAT",
      "answer": "pred ~$1.35 vs. cons $1.13",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Medicaid HBR (2Q26)",
      "prediction": "IN-LINE",
      "answer": "pred ~93.5% vs. cons 93.96%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Commercial/Marketplace HBR (2Q26)",
      "prediction": "BEAT",
      "answer": "pred ~80.5% vs. cons 82.5%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Adj. EPS floor (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide ~>$3.70 vs. cons $3.53",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "HBR range (FY 2026)",
      "prediction": "UNCHANGED",
      "answer": "guide 90.9%-91.7% vs. cons 90.97% midpoint",
      "confidence": "HIGH"
    },
    {
      "kpi": "Marketplace qualitative (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide pretax margin toward ~4% vs. embedded ~3%",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 5.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 3.0,
  "day5_path": "STABILIZE",
  "day5_rationale": "STABILIZE \u2014 archetype A follow-through compressed by elevated +29% pre-print run; initial pop partially fades as profit-taking offsets estimate revision tailwind",
  "day5_confidence": "MEDIUM"
}